Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLR versus fosfomycin for acute uncomplicated lower urinary tract infection in women
2013-004529-99Phase 3Completed
- Sponsor
- Bionorica
- Start
- Aug 2015
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bacterial cystitis comparing CLR arm with Fosfomycin trometamol arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started Aug 2015; status: completed.
02
Drugs
Canephron-Nfosfomycin
03
Conditions
bacterial cystitis
Beyond the preview
Go deeper on 2013-004529-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004529-99.